Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Biden transition and vaccine hopes drive up stocks, oil and bitcoin

Tue, 24th Nov 2020 12:35

* Risk currencies gain as uncertainty retreats

* Vaccine could be released by mid-December

* Trump, government officials nod to formal Biden transition

* Bitcoin hits 19,000

* For a Reuters live blog on U.S., UK and European stock
markets,
click LIVE/ or type LIVE/ in a news window.

By Lawrence White and Julie Zhu

LONDON/HONG KONG, Nov 24 (Reuters) - Stocks, oil and risk
currencies, including bitcoin, gained on Tuesday as U.S.
President-elect Joe Biden got the formal go-ahead to begin his
transition to the White House.

The world's most popular cryptocurrency rose 3%
to near its record high, leading a surge in risk appetite as the
European STOXX 600 index climbed 0.6% and Brent
crude rose to its highest level since March at $46.52 a
barrel. Safe-haven assets such as gold fell.

After weeks of legal challenges to the election results,
U.S. General Services Administration chief Emily Murphy wrote to
Biden on Monday informing him the formal handover process could
begin.

President Donald Trump tweeted that he had told his team "do
what needs to be done with regard to initial protocols", an
indication he was moving towards a transition.

"Markets have been constrained by very high levels of
uncertainty on the U.S. political front and around vaccines for
weeks, so with those two going away investors are considering
the prospect of a return to normality in 2021," said Emmanuel
Cau, head of European equity strategy at Barclays.

Reports that Biden plans to nominate former Federal Reserve
Chair Janet Yellen to become the next Treasury Secretary further
boosted U.S. stocks on expectations she would pursue more
conventional policies than the departing Steven Mnuchin.

Futures for the S&P 500 rose 0.8% in European
trading hours, putting the 49-country MSCI world stocks index on
course to set a record high later.

Later on Tuesday, Biden and Vice President-elect Kamala
Harris are expected to formally introduce their appointments to
critical national security and foreign policy positions in
Wilmington, Delaware.

Japan's Nikkei jumped 2.5% to its highest level
since May 1991 overnight, with energy, real estate and financial
shares leading the advance.

Asia-Pacific shares outside Japan had ticked
up 0.4%. Australia's S&P/ASX 200 was 1.26% stronger,
touching its highest level in almost nine months, with energy
stocks leading the pack there.

Chinese blue chips were an outlier among positive
Asian shares, edging down 0.6%, as investors booked profits
following recent strong gains.

RISK ON

AstraZeneca and Oxford University said on Monday
that their COVID-19 vaccine, which is cheaper to make, easier to
distribute and faster to scale up than its rivals, could be as
much as 90% effective.

The progress made on COVID-19 vaccines helped drive risk
appetite, as investors looked past short-term economic pain from
the pandemic to a brighter 2021.

The South African rand and the Russian rouble
extended this week's winning run. MSCI's index of emerging
markets equities held the 32-month high reached in the
previous session.

The New Zealand dollar was also among the currency
gainers, rising as much as 0.9% to a two-year high of $0.6986 as
its central bank said house prices, which have been climbing
higher this year, could be included in its inflation basket.

The euro was gaining towards $1.19 again and the
dollar index, which tracks the dollar against a basket of
six major currencies, nudged down to 92.242.

Bitcoin broke past $19,000 for the first time in
nearly three years, as demand for assets perceived as resistant
to inflation grows.

Also spurred on by the vaccine hopes, oil reached levels not
seen since before the coronavirus pandemic began to spread in
March.

Brent crude futures rose 39 cents, or 0.9%, to
$46.45 a barrel to add to a more than 20% surge this month. U.S.
West Texas Intermediate crude added 46 cents, or 1.1%, to
$43.52.

"Progress on developing and distributing a vaccine de-risks
the path back to normal for oil markets," said Stephen Innes,
chief global markets strategist at financial services firm Axi.

SHORT-TERM PAIN

Amid the gains on Tuesday, however, were some reminders of
how the COVID-19 pandemic is inflicting economic pain. Germany's
gross domestic product grew by a record 8.5% in the third
quarter, but the Ifo institute's survey of business morale
pointed to fears of a recession to come as the index fell to
90.7 from a downwardly revised 92.5 in October.

The Turkish lira fell almost 1.5% to trade at 7.9899
per dollar, its weakest since Nov. 11, as new coronavirus
restrictions began and investors look for signs of sustained
central bank support.

In the bond markets, the yield on the U.S. benchmark 10-year
notes rose slightly to 0.87% as did those on most
European government bonds. Germany's 10-year yield was up 1
basis point to -0.58% in morning trade.

Gold fell 1% to $1,814 an ounce, having dropped 10%
this month.

(Reporting by Lawrence White, Julie Zhu and Katanga Johnson;
editing by Shri Navaratnam, Philippa Fletcher, Nick Macfie,
Larry King
For Reuters Live Markets blog on European and UK stock markets,
please click on:)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.